{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Home
  • Live
  • On-Demand
  • RSS/Grand Rounds
  • Non-Accredited
  • About
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

MD Anderson workforce members:  Select "MD ANDERSON LOGIN" and enter your MD Anderson email address and password.

Guests (all other than MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

MD ANDERSON LOGIN
GUEST LOGIN
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Updates on Advanced Breast Cancer: Local Management and Other New Perspectives


LIVECMEBreast Cancer
Updates on Advanced Breast Cancer: Local Management and Other New Perspectives Banner

  • Overview
  • Faculty
  • Schedule
  • Exhibitors
Add to Calendar Updates on Advanced Breast Cancer: Local Management and Other New Perspectives 5/13/2022 8:00:00 AM 5/14/2022 4:00:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/ABC2022 Description: This educational activity aims to enhance the knowledge of oncologists in the management of advanced breast cancer and how to implement the emerging therapies and cutting edge techniques into day-to-day practice. This activity will present the latest research updates and treatment trends/guidelines for triple-negative breast cancer, inflammatory breast cancer, locally advanced breast cancer and metastatic breast cancer.... Marriott Medical Center Hotel Houston false MM/DD/YYYY


Date & Location
Friday, May 13, 2022, 8:00 AM - Saturday, May 14, 2022, 4:00 PM, Marriott Medical Center Hotel Houston

Target Audience
Professions - Nurse - RN, Other, Physician (MD or DO), Physician Associate, Student or Trainee

Credits
AMA PRA Category 1 Credits™ (9.75 hours), Non-Physician Attendance (9.75 hours)

Overview
This educational activity aims to enhance the knowledge of oncologists in the management of advanced breast cancer and how to implement the emerging therapies and cutting edge techniques into day-to-day practice. This activity will present the latest research updates and treatment trends/guidelines for triple-negative breast cancer, inflammatory breast cancer, locally advanced breast cancer and metastatic breast cancer. Experts from both inside and outside of MD Anderson will address the importance of applying a multidisciplinary team approach to develop methods for identification of specific genomic and proteomic signatures of breast cancer. Clinical scenarios will be discussed to provide examples of a high level of patient-focused, multidisciplinary care a breast cancer patient should receive. Experts will also present on current clinical trials that offer novel therapies to treat advanced, rare and aggressive breast cancers. The goal is for physicians to develop the tools to diagnose, identify therapeutic approaches specifically for treatment of breast cancer, enhance approaches to assist in detecting the disease evaluate the effectiveness of treatment for advanced breast cancer patients, and appropriately refer patients to clinical trials if needed after the understanding of available therapy.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Conduct a timely recognition and diagnosis of inflammatory and triple-negative breast cancer, and provide appropriate delivery of therapy that involves multidisciplinary care.
  2. Apply the updated management of locally advanced, recurrent breast cancer.
  3. Apply the updated personalized care for metastatic breast cancers, and refer patients to an appropriate clinical trial.
  4. Apply the updated knowledge on new biological findings/genomic information into the clinical translation.

Registration
The two-day Updates on Advanced Breast Cancer: Local Management and other New Perspectives will begin on Friday, May 13, 2022, with Opening Remarks at 8:00 am and will adjourn for the day at 3:50 pm.  The conference will reconvene on Saturday, May 14, 2022 at 8:00 am and adjourn at 4:00 pm.

 

CLICK FOR AGENDA

Advanced registration is encouraged. If you are considering attending, please use the link below to create a profile in PEP prior to arrival at the conference.

https://mdanderson.cloud-cme.com/default.aspx

The deadline for advanced registration is Wednesday, April 29, 2022.

 

 CONFERENCE REGISTRATION FEES

  • Physicians – MDs (Non-Hal, TMC Members) - Before April 29, 2022 - $50.00
  • Physicians – MDs (Non-Hal, TMC Members) - After April 29, 2022 - $70.00
  • Physicians – MDs (Hal, TMC Members, MDACC) - Before April 29, 2022 - $35.00
  • Physicians – MDs (Hal, TMC Members, MDACC) - After April 29, 2022 - $45.00
  • PhDs, Healthcare Professionals, Trainees - Exempt
  • Patients, Caregivers, Advocates, Volunteers - Exempt
  • Virtual Attendance - live internet streaming (details and login information will be provided via emailed the week of the conference)

For more information, please call Continuing Professional Education (CPE) at 713-792-2223.

 

 We accept the following forms of payment:

  • Credit Cards (MasterCard, VISA, and American Express)
  • Check made payable to: The University of Texas MD Anderson Cancer Center (payable through U.S. banks only)
Mail to:
    Continuing Professional Education – Unit 1781
    The University of Texas MD Anderson Cancer Center
    P.O. Box 301407
    Houston, Texas 77230-1407
 

Telephone registrations are not accepted.

 
When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.
 
Refund/Cancellation Policy
 
The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of the Department of Continuing Professional Education (CPE), is limited to the registration fee. Continuing Professional Education (CPE), will refund the full registration fee. 
 
The Department of Continuing Professional Education (CPE), reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 
 
For additional information, contact Continuing Professional Education (CPE), at 713-792-2223 or toll free at 866-849-5866 or via
e-mail: [email protected]. 
 
Special Assistance
 
Contact the Department of Continuing Professional Education (CPE), at 713-792-2223 or toll free at 866-849-5866 if you have any ADA accommodation needs.

Accreditation
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live internet course for a maximum of 12.50 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity..

 

 


Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 




The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.



Mitigation of Relevant Financial Relationships


The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Eric Gagneaux
Continuing Education Planner
MD Anderson Cancer Center
Activity Administrator
Nothing to disclose
Josh Newby, BA
Baylor College of Medicine
Activity Coordinator, Faculty
Nothing to disclose
Maher Karam, MD
Maher
UT MD Anderson Cancer Center
CE Reviewer
Nothing to disclose
Bora Lim, MD
Associate Professor
Baylor College of Medicine
Co-Director, Faculty
Nothing to disclose
Mediget Teshome, MD
Associate Professor, Breast Surgical Oncology
MD Anderson Cancer Center
Co-Director, Faculty
Nothing to disclose
Bethany Aiena, PhD
Clinical Psychologist
Michael E. DeBakey VAMC
Faculty
Nothing to disclose
Igor Bado, PhD
Baylor College of Medicine
Faculty
Nothing to disclose
Elizabeth Bonefas, MD
Breast Health Houston
Faculty
Nothing to disclose
Paula D Bos, PhD
Assistant Professor
Virginia Commonwealth University School of Medicine
Faculty
Nothing to disclose
Mary Cavanaugh, APRN, MSN, NP-C, ANP
Nurse practitioner
Cavanaugh
Faculty
Nothing to disclose
Isaac Chan, MD, PhD
UT Southwestern
Faculty
Nothing to disclose
Ecaterina E Dumbrava, MD
Assistant Professor - Invest. Cancer Therapeutics
MD Anderson Cancer Center
Faculty
Advisor-BOLT Therapeutics|Advisor-Mersana
Gloria V Echeverria, PhD
Assistant Professor
Baylor College of Medicine
Faculty
Nothing to disclose
Suzanne Fuqua, PhD
Professor
Baylor College of Medicine
Faculty
Nothing to disclose
Valentina Hoyos, MD
Assistant Professor
United Healthcare
Faculty
Royalties or Patent Beneficiary-Takeda Pharmaceutical (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Allovir|Stocks or stock options, excluding diversified mutual funds-Marker Therapeutics
David Hui, MD
University of Texas MD Anderson Cancer Center
Faculty
Paid consultant-Eton Pharmaceuticals
Abbey J Kaler, MS
Advanced Prac Registered Nurse, Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Rachel M Layman, MD
Professor
MD Anderson Cancer Center
Faculty
Grant or research support-Lilly USA, LLC|Paid consultant-Lilly USA, LLC|Grant or research support-Novartis Pharmaceuticals Corporation|Paid consultant-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-Pfizer Inc.|Grant or research support-GlaxoSmithKline (Relationship has ended)|Grant or research support-Puma|Grant or research support-Zentalis|Grant or research support-Celcuity|Paid consultant-Celcuity (Relationship has ended)
Maryam B Lustberg, MD, MPH
Yale
Faculty
Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-AstraZeneca US|Consulting Fee-Lilly USA, LLC|Consulting Fee-Pfizer Inc.|Advisor-Sanofi US (Relationship has ended)|Independent Contractor (included contracted research)-Hologic, Inc.
Filipa Lynce, MD
Dana-Farber Cancer Institute
Faculty
Grant or research support-AstraZeneca US|Grant or research support-Zentalis|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-CytomX|Grant or research support-Pfizer Inc. (Relationship has ended)|Grant or research support-Bristol-Myers Squibb Company (Relationship has ended)|Advisor-AstraZeneca US|Advisor-Daiichi Sankyo, Inc. (Relationship has ended)|Advisor-Bristol-Myers Squibb Company (Relationship has ended)
Zeyad A Metwalli, MD
Dr.
MD Anderson Cancer Center
Faculty
Nothing to disclose
Nicholas Navin, PhD
Dr.
MD Anderson Cancer Center
Faculty
Nothing to disclose
Laura Stevens, PhD
Dana Farber Cancer Institute
Faculty
Nothing to disclose
Paolo Tarantino, MD
Dana-Farber Cancer Institute
Faculty
Advisor-AstraZeneca US (Relationship has ended)
Claudio E Tatsui, MD
Associate Professor
MD Anderson Cancer Center
Faculty
Nothing to disclose
Alastair Thompson, MD, FRCSEd FACS
Professor
Baylor College of Medicine
Faculty
Nothing to disclose
Nisha Unni, MD
M.D
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
Faculty
Advisor-AstraZeneca US (Relationship has ended)|Advisor-Gilead Sciences, Inc. (Relationship has ended)|Advisor-Novartis Pharmaceuticals Corporation (Relationship has ended)|Advisor-Lilly USA, LLC (Relationship has ended)|Advisor-Sanofi US (Relationship has ended)|Advisor-Eisai, Inc. (Relationship has ended)|Advisor-Biotheranostics (Relationship has ended)|Advisor-Macrogenics (Relationship has ended)
Steven Van Laere, PhD
Professor
Antwerp University
Belgium
Faculty
Nothing to disclose
Clinton Yam, MD
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-Genentech, Inc.-|Grant or research support-Merck and Company, Inc.-|Grant or research support-Amgen-
Timothy A Yap, MD, PhD
Associate Professor, Invest. Cancer Therapeutics
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-AstraZeneca|Grant or research support-Artios|Grant or research support-Bayer HealthCare Pharmaceuticals, Inc.|Grant or research support-Beigene|Grant or research support-BioNTech|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Clovis Oncology|Grant or research support-Constellation|Grant or research support-Cyteir|Grant or research support-Eli Lilly|Grant or research support-EMD Serono Inc.|Grant or research support-Forbius|Grant or research support-F-Star|Grant or research support-GlaxoSmithKline|Grant or research support-Genentech, Inc.|Grant or research support-Haihe|Grant or research support-ImmuneSensor|Grant or research support-Ionis|Grant or research support-Ipsen US|Grant or research support-Jounce|Grant or research support-Karyopharm Therapeutics|Grant or research support-KSQ|Grant or research support-Kyowa|Grant or research support-Merck|Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-Pfizer Inc.|Grant or research support-Repare|Grant or research support-Ribon Therapeutics|Grant or research support-Regeneron Pharmaceuticals, Inc.|Grant or research support-Rubius|Grant or research support-Sanofi|Grant or research support-Scholar Rock|Grant or research support-Seattle Genetics, Inc.|Grant or research support-Tesaro|Grant or research support-Vivace|Consulting Fee-AstraZeneca|Grant or research support-Acrivon|Grant or research support-Blueprint|Grant or research support-Mirati|Grant or research support-Zenith|Consulting Fee-Almac|Consulting Fee-Aduro|Consulting Fee-Artios|Consulting Fee-Athena|Consulting Fee-Atrin|Consulting Fee-Axiom|Consulting Fee-Bayer HealthCare Pharmaceuticals, Inc.|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Calithera|Consulting Fee-Clovis Oncology|Consulting Fee-Cybrexa|Consulting Fee-EMD Serono Inc.|Consulting Fee-F-Star|Consulting Fee-GLG|Consulting Fee-Guidepoint|Consulting Fee-Ignyta|Consulting Fee-I-Mab|Consulting Fee-ImmuneSensor|Consulting Fee-Jansen|Consulting Fee-Merck|Consulting Fee-Pfizer Inc.|Consulting Fee-Repare|Consulting Fee-Roche|Consulting Fee-Schrodinger|Consulting Fee-Varian Medical Systems, Inc|Consulting Fee-Zai Labs|Consulting Fee-ZielBio|Consulting Fee-AbbVie Inc.|Consulting Fee-AstraZeneca US|Consulting Fee-Acrivon|Consulting Fee-Adagene|Consulting Fee-Amphista|Consulting Fee-Avoro|Consulting Fee-Baptist Health Systems|Consulting Fee-Beigene|Consulting Fee-Boxer|Consulting Fee-C4 Therapeutics|Consulting Fee-Cancer Research UK|Consulting Fee-Diffusion|Consulting Fee-Genmab|Consulting Fee-Glenmark|Consulting Fee-Globe Life Sciences|Consulting Fee-GSK|Consulting Fee-Idience|Consulting Fee-Institut Gustave Roussy|Consulting Fee-Intellisphere|Consulting Fee-Kyn|Consulting Fee-MEI Pharma|Consulting Fee-Mereo|Consulting Fee-Natera|Consulting Fee-Nexys|Consulting Fee-Novocure|Consulting Fee-OHSU; OncoSec|Consulting Fee-Ono Pharma; Pegascy; PER|Consulting Fee-Piper-Sandler; Prolynx; resTORbio|Consulting Fee-Theragnostics; Versant|Consulting Fee-Vibliome|Consulting Fee-Xinthera|Employment-University of Texas MD Anderson Cancer Center, where I am Medical Director of the Institute for Applied Cancer Science, which has a commercial interest in DDR and other inhibitors (e.g. IACS30380/ART0380 was licensed to Artios)|Stocks or stock options, excluding diversified mutual funds-Seagen
Bing Zhang, PhD
Professor
BAYLOR COLLEGE OF MEDICINE
Faculty
Nothing to disclose
Siyuan Zhang, MD, PhD
Associate Professor
University of Texas Southwestern Medical Center
Faculty
Nothing to disclose
Xiang Zhang, PhD
William T. Butler Endowed Professor
Baylor College of Medicine
Faculty
Nothing to disclose

Friday, May 13, 2022
Welcome and Conference Goals
8:00AM - 8:20AM
Bora Lim, MD
Mediget Teshome, MD
Session 1: Updates in Treatment of Avdvance IBC
8:20AM - 8:40AM
Steven Van Laere, PhD
Updates in Treatment of Avdvance IBC
8:40AM - 9:00AM
Bora Lim, MD
Updates in Treatment of Avdvance IBC
9:00AM - 9:20AM
Filipa Lynce, MD
Break
9:20AM - 9:40AM
Session 2: Clinical Advances in Advanced Breast Cancer Subtypes
9:40AM - 10:00AM
Clinton Yam, MD

Topic: Triple Negative
Clinical Advances in Advanced Breast Cancer Subtypes
10:00AM - 10:20AM
Timothy A Yap, MD, PhD

Topic: BRCA / DNA Damage
Clinical Advances in Advanced Breast Cancer Subtypes
10:20AM - 10:40AM
Rachel M Layman, MD

Topic: ER+
Clinical Advances in Advanced Breast Cancer Subtypes
10:40AM - 11:00AM
Paolo Tarantino, MD
Session 3: Palliative Local Therapy in Advanced Breast Cancer
11:00AM - 11:20AM
Zeyad A Metwalli, MD
Palliative Local Therapy in Advanced Breast Cancer
11:20AM - 11:40AM
Claudio E Tatsui, MD
Palliative Local Therapy in Advanced Breast Cancer
11:40AM - 12:00PM
Elizabeth Bonefas, MD
Lunch
12:00PM - 1:00PM
Session 4: Omics Driven Precision Medicine in Advanced Breast Cancer
1:00PM - 1:20PM
Laura Stevens, PhD
Omics Driven Precision Medicine in Advanced Breast Cancer
1:20PM - 1:40PM
Bing Zhang, PhD
Omics Driven Precision Medicine in Advanced Breast Cancer
1:40PM - 2:00PM
Igor Bado, PhD
Break
2:00PM - 2:15PM
Session 5: Immunology
2:15PM - 2:35PM
Paula D Bos, PhD
Immunology
2:35PM - 3:00PM
Valentina Hoyos, MD
Session 6: Keynote Presentation
3:00PM - 3:30PM
Bora Lim, MD (Moderator)
Maryam B Lustberg, MD, MPH
Adjourn
3:30PM - 3:35PM
Saturday, May 14, 2022
Welcome and Conference Goals
7:50AM - 8:00AM
Bora Lim, MD
Mediget Teshome, MD
Session 7: Keynote Presentation
8:00AM - 8:30AM
Siyuan Zhang, MD, PhD
Session 8: Emerging Therapeutics in Treatment of Advanced Breast Cancer
8:30AM - 8:50AM
Isaac Chan, MD, PhD
Emerging Therapeutics in Treatment of Advanced Breast Cancer
8:50AM - 9:10AM
Nisha Unni, MD
Emerging Therapeutics in Treatment of Advanced Breast Cancer
9:10AM - 9:30AM
Ecaterina E Dumbrava, MD
Break
9:30AM - 9:40AM
Session 9: Quality of Life for Advanced Breast Cancer Patients
9:40AM - 10:00AM
David Hui, MD
Quality of Life for Advanced Breast Cancer Patients
10:00AM - 10:20AM
Bethany Aiena, PhD
Quality of Life for Advanced Breast Cancer Patients
10:20AM - 10:40AM
Mediget Teshome, MD
Quality of Life for Advanced Breast Cancer Patients
10:40AM - 11:00AM
Josh Newby, BA
Session 10: Selected Topics in Advanced Breast Cancer
11:00AM - 11:30AM
Suzanne Fuqua, PhD
Selected Topics in Advanced Breast Cancer
11:30AM - 12:00PM
Nicholas Navin, PhD
Lunch
12:00PM - 1:00PM
Introduction - Advocate Program (No CME awarded for this session)
1:00PM - 1:10PM
Josh Newby, BA (Moderator)
Newly Diagnosed, Now What? - Panel Discussion (No CME awarded for this session)
1:10PM - 2:00PM
Bora Lim, MD
Mediget Teshome, MD
Isaac Chan, MD, PhD
Creating a Community of MBC Patients and Advocates (No CME awarded for this session)
2:00PM - 2:50PM
Abbey J Kaler, MS
Wrap Up and Setup Yoga Session
2:50PM - 3:00PM
Patient Yoga Session (No CME awarded for this session)
3:00PM - 3:30PM
Mary Cavanaugh, APRN, MSN, NP-C, ANP
Advocate Program Closing (No CME awarded for this session)
3:30PM - 4:00PM
Bora Lim, MD
Josh Newby, BA
Abbey J Kaler, MS
Adjourn
4:00PM - 4:00PM


Contact Us:
Kelley Gilpin
The University of Texas MD Anderson Cancer Center
7007 Bertner Ave., Unit 1781, Ste. 1MC16.2343
Houston, TX 77030
Phone: 17135630603
Email: [email protected]


W9 Form Promotional Items Exhibit at this Event

Exhibitor Packages

Exhibitor Package - Gold Price: $10000.00
Includes:
  • Recognition as a Gold Exhibitor
  • 6ft. Tabletop display with linens and two chairs
  • Number of Exhibitor Badges: 5
  • Complimentary breakfast, lunch and refreshments (available with Exhibitor Badge)
  • Product to be shipped directly to facility by exhibitor at own cost. Call for details.
  • Exhibit Location: Premium Assigned
  • Promotional Items:
    • Additional Exhibitor Badge
    • Two Additional Exhibitor Badges

Deadline for order commitment is 5/12/2022 12:00:00 AM.

Exhibitor Package - Silver Price: $7500.00
Includes:
  • Recognition as a Silver Exhibitor
  • 6ft. Tabletop display with linens and two chairs
  • Number of Exhibitor Badges: 3
  • Complimentary breakfast, lunch and refreshments (available with Exhibitor Badge)
  • Product to be shipped directly to facility by exhibitor at own cost. Call for details.
  • Exhibit Location: Premium Assigned
  • Promotional Items:
    • Additional Exhibitor Badge
    • Two Additional Exhibitor Badges

Deadline for order commitment is 5/12/2022 11:00:00 PM.

Exhibitor Package - Bronze Price: $5000.00
Includes:
  • Recognition as a Bronze Exhibitor
  • 6ft. Tabletop display with linens and two chairs
  • Number of Exhibitor Badges: 2
  • Complimentary breakfast, lunch and refreshments (available with Exhibitor Badge)
  • Product to be shipped directly to facility by exhibitor at own cost. Call for details.
  • Exhibit Location: Assigned
  • Promotional Items:
    • Additional Exhibitor Badge
    • Two Additional Exhibitor Badges

Deadline for order commitment is 11/30/2022 12:00:00 AM.

Promotional Items

Exhibitor Promotional Option - Additional Exhibitor Badge Price: $400.00
Additional exhibit representative registration is $400 per person

Deadline for order commitment is 5/12/2022 12:00:00 AM.

Exhibitor Promotional Option - Two Additional Exhibitor Badges Price: $800.00
Additional exhibit representative registration is $400 per person

Deadline for order commitment is 5/12/2022 12:00:00 AM.

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2023 The University of Texas MD Anderson Cancer Center
Contact Us: [email protected]

See us on Facebook See us on Twitter See us on Linked In See us on Instagram